Microbiology Core
Microbiology Core
批准号:
9103001
负责人:
Guangchun Bai
金额:
$25.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2019-07-31
关键词:
AccidentsAddressAnimal ExperimentsAnimal HusbandryApplications GrantsCenters for Disease Control and Prevention (U.S.)ContainmentDecontaminationEmergency responseEnsureEquipmentExhibitsFrancisella tularensisGoalsHuman ResourcesImmune responseImmunobiologyIndividualMaintenanceMicrobiologyModelingMusOutcomePathogenesisPeer ReviewProceduresProductivityProtocols documentationPublicationsPulmonary tularemiaQuality ControlReagentRecordsResearchResearch PersonnelResource SharingRunningSafetySecuritySourceTimeTrainingVertebratesWorkanimal facilitybiosafety level 3 facilitymedical schoolsmutantoperationorganizational structureprogramsresearch study
中文摘要
我们选择代理研究计划的核心是ABSL 3/BSL 3/NIHBL 3设施。目的
ABSL 3/BSL 3/NIHBL 3核心(核心B)的主要目的是提供高质量、均匀的弗朗西斯菌来源
土拉热(Ft),避免重复工作,并为所有研究者提供共享资源。其基本原理是
一个由训练有素的技术人员管理的集中设施将能够最好地始终如一地产生可靠的
项目的所有组成部分的试剂。核心B的主要目标是确保
维护和供应细菌储备;提供ABSL 3畜牧业和维护
ABSL 3/BSL 3/NIHBL 3设施;并为在该套房工作的个人提供培训和监督。到
为了实现这些目标,核心B将:
1.保持Ft SchuS 4储备培养物。
2.提供动物饲养和BSL 3设施维护。
3.提供培训和监督。
英文摘要
Central to the efforts of our Select Agent research program is the ABSL3/BSL3/NIHBL3 facility. The purpose
of the ABSL3/BSL3/NIHBL3 core (Core B) is to provide a high quality, uniform source of Francisella
tularensis (Ft), avoid duplication of work, and provide a shared resource for all investigators. The rationale is
that a centralized facility run by trained technicians will be best able to consistently generate reliable
reagents for all components of the Program Project. The primary objectives of Core B are to ensure proper
maintenance and supply of bacterial stocks; to provide ABSL3 animal husbandry and maintenance of the
ABSL3/BSL3/NIHBL3 facility; and to provide training and oversight to individuals working in the suite. To
achieve these goals, Core B will:
1. Maintain Ft SchuS4 stock cultures.
2. Provide animal husbandry and BSL3 facility maintenance.
3. Provide training and oversight.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel c-di-AMP-based recombinant BCG vaccine
-
批准号:10667007
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2023
-
负责人:Guangchun Bai
-
依托单位:
Microbiology Core
-
批准号:8698577
-
项目类别:
-
资助金额:$27.79万
-
财政年份:--
-
负责人:Guangchun Bai
-
依托单位:
Microbiology Core
-
批准号:8711177
-
项目类别:
-
资助金额:$23.96万
-
财政年份:--
-
负责人:Guangchun Bai
-
依托单位:
海外基金